Press releases

12
May 2025
20:30 E.S.T.

Cellectis Reports Financial Results for the First Quarter 2025

Read more
12
May 2025
09:30 E.S.T.

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Read more
6
May 2025
20:30 E.S.T.

Cellectis to Report First Quarter Financial Results on May 12, 2025

Read more
28
Apr 2025
20:30 E.S.T.

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Read more
13
Mar 2025
22:15 E.S.T.

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Read more
7
Mar 2025
09:36 E.S.T.

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Read more
24
Feb 2025
06:30 E.S.T.

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Read more
10
Dec 2024
19:50 E.S.T.

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

Read more
5
Nov 2024
21:30 E.S.T.

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

Read more
4
Nov 2024
21:30 E.S.T.

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US